EMA Launches New Initiatives to Advance Women's Health Research and Regulation

The European Medicines Agency (EMA) has introduced a series of initiatives aimed at improving women's health research and regulation. These measures seek to address existing gaps in research, diagnosis, and treatment, ensuring that medicines are developed and assessed to better meet women's specific healthcare needs. Key areas of focus include strengthening clinical trials, research on pregnancy and breastfeeding, and updating medicine labeling.